Care transition intervention for patients with advanced cancer after hospital discharge
Official title: Randomized Trial of a Care Transition Intervention for Hospitalized Patients with Advanced Cancer
Run by Massachusetts General Hospital · NCT05142345 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a new video visit program with an oncology nurse for patients with advanced cancer after they leave the hospital to see if it helps them feel more confident and satisfied with their care while reducing the chances of going back to the hospital.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 286 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 1 site (Boston, Massachusetts) |
| Trial ID | NCT05142345 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a recent unplanned admission for advanced cancer at Massachusetts General Hospital.
✕Probably not a fit
Patients who were admitted electively or discharged to locations other than home, or those who expired during admission, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines the CONTINUUM intervention, which involves a supportive care-focused video visit with an oncology nurse practitioner within three business days of hospital discharge for patients with advanced cancer. The goal is to improve post-discharge transitions of care by reconciling medications, managing symptoms, reviewing care plans, and scheduling follow-up appointments. The study will compare the effectiveness of this intervention against standard care in enhancing patient confidence, satisfaction with communication, and reducing hospital readmissions within 30 days.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the management of health conditions and reduce hospital readmissions for patients with advanced cancer.
How similar studies have gone: Previous pilot trials have shown that similar interventions can be feasible and acceptable, indicating potential for success in this randomized controlled trial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>= 18 years * First unplanned admission to the oncology service at Massachusetts General Hospital (MGH) since diagnosis of advanced cancer * Known diagnosis of advanced breast, thoracic, genitourinary, or gastrointestinal cancer * Receiving ongoing oncology care at MGH * Verbal fluency in English * Internet/wifi or telephone access * Residing in Massachusetts at the time of hospital discharge Exclusion Criteria: * Admitted electively * Discharged to a location other than home or expired during admission * Discharged with hospice services
Where it's running
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Daniel E Lage, MD — Massachusetts General Hospital
- Study coordinator: Daniel E Lage, MD
- Email: dlage@mgh.harvard.edu
- Phone: (617) 724-4000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Concise coaching to guide decisions for advanced cancer patients considering palliative procedures
A coaching program delivered by lay providers will test whether it helps adults with advanced cancer make better, patient-aligned decisions about palliative surgeries or similar interventions.
-
Primary Palliative Care: A Feasibility Project for Family Health Units
This feasibility trial tests a GP training program plus a structured 12-week palliative-care visit plan to see if it can be carried out in primary care for adults with advanced illness.
-
Virtual Group Resilient Living for Advanced Cancer
A group-based online program tests whether seven weekly sessions can reduce anxiety and fatigue and improve quality of life for adults with advanced cancer.
-
IV contrast-enhanced CBCT with HyperSight for image guidance in advanced cancer radiotherapy
This study tests whether giving IV contrast during cone-beam CT helps doctors see the tumor better during radiotherapy in people with advanced cancer.
-
Single-session celiac plexus SBRT using a simulation-free adaptive workflow for cancer-related pain
A pilot test to see if a one-day, simulation-free adaptive radiotherapy process can safely deliver celiac plexus SBRT to adults with advanced pancreatic or other cancers.
-
UI-102 in advanced cancers (phase 1/2) first-in-human
A first-in-human study tests UI-102, given to adults with advanced solid tumors to see if it is safe and shows signs of benefit.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.